https://parisnordmoto.com/1a3bn1i1db4 The 24th Chinese Biopharmaceutical Association Annual Conference
Transforming Biopharmaceutical and Healthcare Industry through Cutting Edge Technologies and Global Partnership
https://flowergardengirl.co.uk/2022/09/14/7zxaq13qnu 美国华人生物制药科技协会（CBA）第24届年会
https://popcultura.com.br/k8jgzaru3 引领生物医药尖端技术，推进产业化和全球合作
https://www.radioculturasd.com.br/1yyjb9q Guangzhou, China https://www.amnow.com/ragtrq7 | Buy Real Valium June 10-11, 2019
https://perfect-deal.nl/uncategorized/r6kd6fw7ng Baiyun International Convention Center
Please click here for Event Registration or use the barcode below.
https://poweracademy.nl/cfua3w8tbr About the ConferenceCBA’s Annual Conference is a leading life science forum, attracting the most influential organizations, scientists, physicians, regulators, investors, and executives from China and US. It is not only an ideal platform to discuss the most recent scientific, regulatory, and business developments, but also creates opportunities for investment and partnership between the US and China. A detailed conference program will be available at www.cba-usa.org shortly. The 24th（2019）CBA annual conference is co-hosted with BioChina (https://www.biochina-gz.com/) The theme is “Transforming biopharmaceutical and healthcare industry through cutting edge technologies and global partnership.” It is to address the critical role of innovative technology and its translation to industry through worldwide collaboration. We have selected enlightening and informative sessions including:
- Artificial Intelligence in Pharmaceutical Industry and Healthcare
- Dual submissions: Shortcut or Pitfall?
- CBA 24 Years of Innovation and Entrepreneurship
- Immuno-oncology and Cutting-edge Technologies
- Precision Medicine
- Latest Advancement of Therapeutic Regimen
- Intellectual Property Protection and Law in Pharmaceutical Industry in China and U.S.
- Global Partnership and Collaboration
- Biopharmaceutical Start-ups, Incubators, and Venture Capitals
- Biopharmace
- Biopharmaceutical incubator and pitch competition (A starting prize pool of $20,000, 1st Prize: $10,000 |2nd Prize: $5,000 |3rd Prize: $3,000;Audience’s Choice: $2,000. All selected projects can attend the conference with partial travel expense coverage)
美国华人生物医药协会（CBA）年会是一个业界领先的生命科学论坛，长期吸引了来自中国和美国的最有影响力的组织，科学家，医生，监管机构，投资者和高管。这不仅是讨论行业最新科学，法律法规和业务发展的理想平台，也为中美之间的投资和合作创造了机会。 详细的会议日程请见www.cba-usa.org 。
第24届（2019）CBA年会与中国生物产业大会（BioChina）合办，主旨是“通过尖端技术和全球合作改变生物制药和医疗行业。”大会探讨通过全球合作，解决通过全球化合作产业转化的问题。我们制定了极具启发性和信息性的会议板块，包括：
- 人工智能在生物医药工业界和健康领域的应用
- 中美双报：研发的捷径还是思想的陷阱?
- CBA 24年创新创业史
- 免疫肿瘤和现代生物医学技术发展趋势
- 精准医学
- 先进疗法的最新进展和应用
- 中美生物医药商务法规和知识产权
- 药物研发和临床实践的全球化
- 产业和资本论坛
- 生物医药初创公司孵化器 及创业路演大赛 (一等奖 10,000美元 | 二等奖 5,000美元 |三等奖 3,000美元 |观众投票奖 2,000 美元. 所有参会项目，主办方将赞助部分差旅费)
Buy Alprazolam 2Mg Day One: 10 Jun 2019 Monday https://ontopofmusic.com/2022/09/sqq5bxsvhy 大会第一天 六月十日 http://pinkfloydproject.nl/vsh9c9pg8 星期一 Buy Xanax 2Mg India
7:30-9:00
Check in/ Registration; 签到/注册
https://www.radioculturasd.com.br/pqr8qy4l 9:00-12:00
12th China Bioindustry Convention Opening Ceremony
Cheap Xanax Pill Press 第十二届中国生物产业大会开幕式及主旨演讲 http://www.youthministrymedia.ca/80fa3555
https://perfect-deal.nl/uncategorized/jisq7qm The Revolution of Personalized Medicine
https://www.kidsensetherapygroup.com/kjdfm2uo 个性化医学的革命
CBA Speaker： Dr. Aaron Ciechanover, Nobel Laureate -2004
阿龙·切哈诺沃博士, 2004年诺奖获得者, 以色列人文和自然科学院院士、美国国家科学院外籍院士、中国科学院外籍院士
12:00-13:30
Connecting and Show; 午餐 联谊 及 展台参观
Buy Diazepam Powder 13:30-15:45
https://pinkcreampie.com/nt7h8kske CBA https://www.amnow.com/dnalohcm5ob 年会主席致词，会长介绍嘉宾 https://faradayvp.com/so0vm3j5ljh , http://mgmaxilofacial.com/jruxt3k1 颁奖
Order Valium 10 Mg Uk Dr. Chuanhua Julia Xing, CBA-USA President-elect, Annual Conference Chair of Organizing Committee
http://pinkfloydproject.nl/7eyjgut0h 邢传华博士，年会主席，候任会长
Dr. Frank Li Li, CBA-USA President , Buy Valium Toronto 李利博士 , https://ontopofmusic.com/2022/09/i1nwrqkh7e 会长
https://www.kidsensetherapygroup.com/acpgcjpvn5t Trends in Digital Health
https://pinkcreampie.com/mqddunj Buy Valium Roche 数字健康的最新趋势
Dr. Simon Kos, Microsoft CMO,
Simon Kos博士, 微软首席医学官
https://poweracademy.nl/ruicxzwjiem Accurate Diagnosis is the Premise and Guarantee of Precision Medicine;
https://flowergardengirl.co.uk/2022/09/14/3jpe6q0t 精准诊断是精准医疗的前提和保证 http://www.youthministrymedia.ca/pplbf39
Dr. Hongyang Wang, Academician, Chinese Academy of Engeering, director of the National Center of Liver Cancer (NSFC)
王红阳, 中国工程院院士, 国家肝癌科学中心主任, 国家自然科学基金委员会医学科学部主任
https://www.radioculturasd.com.br/yvw09upyjs Genetics and Genomics of Cancer
Cheap Valium For Sale https://poweracademy.nl/weqmcbnip1 癌症的遗传学和基因组学
Dr. Raju Kucherlapati, Professor of Medicine, Harvard Medical School. The National Academy of Medicine
Raju Kucherlapati 院士，哈佛大学医学院
https://www.kidsensetherapygroup.com/i0qmmzci410 Buy Soma In Us Frontier of Biopharmaceutical Technologies and Development Trend in China
https://www.amnow.com/ev7w94ug http://www.youthministrymedia.ca/0hpibsp 生物医药科技前沿动向和我国发展态势
Dr. Kaixian Chen, Academisian, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
陈凯先, 中国科学院院士, 中国科学院上海药物研究所
Buy Alprazolam Eu Drug review and accelerating new drug development
http://mgmaxilofacial.com/ysmh5tk4u9p 药品审评审批与加快新药研发
Dr. Alex Xu, Chief Scientist, NMPA/CDE, Former FDA senior reviewer
徐增军, 中国药监局药品审评中心首席科学家, 前美国FDA资深评审员
Innovation Practice of Whole Life Science Industry Chain
https://faradayvp.com/pwncggpsvme Buy Diazepam 10Mg Teva 生命科学产业全周期创新实践
Jianguo Yan, Chairman of China Resources Life Sciences Company
颜建国 ， 华润生命科学产业发展有限公司董事长
Forum 1: Artificial Intelligence in Pharmaceutical Industry and Healthcare
人工智能在生物医药工业界和健康领域的应用
Chair/主席: Dr. Hongtu Zhu, IMS and ASA Fellow, Professor of Biostatistics, UNC at Chapel Hil； 朱宏图博士
Big Data Integration in Clinical Reseach,
医疗人工智能图像处理
Dr. Hongtu Zhu, IMS and ASA Fellow, Professor of Biostatistics, UNC at Chapel Hill
朱宏图博士， 美国北卡大学教堂山分校教授
New drug development and cancer treatment personalized customization based on artificial intelligence and synthetic lethality
基于人工智能和合成致死的新药研发和肿瘤治疗个性化定制
Bin Li, Alphacait CEO
李斌 ， 阿耳法猫 总裁
AI Guided Digital Colposcopy Diagnosis System for Cervial Cancer Screening
宫颈癌人工智能电子阴道镜辅助诊断系统研究
Youlin Qiao, MD, PhD, Director for Department of Cancer Epidemiology, Cancer Hospital, Chinese Academy of Medical Sciences and
Peking Union Medical College
乔友林医学博士, 教授，中国医学科学院肿瘤医院流行病学教研室主任 ，北京协和医学院
Forum 2: Dual Submissions: Shortcut or Pitfall? 中美双报：捷径还是陷阱?
Chair/主席:： Dr. Julia Luan 栾景宇博士, CBA董事会成员，美国药物研发监管科学家
Dual Submissions in China and US: Theory and Practice;
中美双报的理论与实践
Dr. Dan Zhang, Executive Chairman of Fountain Medical Development Ltd
张丹博士, 方恩医药发展公司董事长
Challenges and Opportunities in Trial Design and Analyses of China/USA Dual Submission
临床试验设计的挑战和机遇以及中美双报分析
Dr. Kazem Kazempour, President and CEO of Amarex Clinical Research, LLC:
Kazem Kazempower博士，Amarex临床研究总裁兼首席执行官
17:00-17:15
Break 茶歇
17:15-18:30
Forum 3: 24 Years CBA’s Innovation and Entrepreneurship CBA 24年创新创业史
Chair/主席: Dr. Dong Shen, Founder and CEO of Nexneo, Inc; 沈栋博士, 美国Nexneo(纳新)公司创始人和首席执行官
Integrate Resources for Entreprenurship and Innovative RNAi Therapeutics
深耕核酸新药创制，整合创业优势资源
Dr. Patrick Lu, Founder, President and CEO of Sirnaomics Inc.
陆阳博士,美国圣诺制药公司创始人，总裁兼首席执行官
Apollomics’ approach to cure cancer
创新在中国，普惠全球， 攻克肿瘤
Dr. Guoliang Yu, Executive Chairman of CrownBio
余国良博士,冠科美博公司执行主席, CBA创始会长
IPO of CanSino
康希诺香港上市故事
Dr.Shou-Bai Chao, COO of CanSino Biologics Inc.
巢守柏博士, 首席运营官，康希诺生物股份公司
Day Two: 11 Jun 2019 Tuesday 大会第二天 六月十一日 星期二
8:30-9:30
Forum 4：Keynote Presentation
院士重磅演讲 引领生物医药尖端技术，推进医药产业化和全球合作 (二)
Digital Medicine: Transforming Care from Chronic Disease to Cancer
数字医药:转变从慢性病到癌症的治疗方式
Lynda Chin, MD, Elected Member of The US National Academy of Medicine, CEO and Founder, Apricity Health;
Professor of Oncology, Dell Medical School
Lynda Chin 医学博士, 美国国家医学院院士, Apricity Health 首席执行官兼创始人, Dell医学院肿瘤系教授
Global Analysis of Proteolysis for Discovery and Benefit to Patient Health
全面分析蛋白酶解方法在科研和患者健康的应用
Charles Craik, PhD，Elected Member of American Academy of Arts and Sciences Professor at UCSF
Charles Craik博士，美国艺术与科学学院院士,加卅大学旧金山分校教授
09:30-11:00
Forum 5: Immuno-Oncology and Front-Edge Technologies 肿瘤免疫疗法和现代生物医学技术发展趋势
Chair/主席: Dr. Mitchell Ho ,Senior Investigator, NCI; NIH, Head of Antibody Therapy ; 何苗壮博士
Single Domain Antibodies and Advances in Cancer Immunotherapy
纳米抗体和肿瘤免疫治疗
Mitchell Ho, PhD, Senior Investigator, NCI, NIH, Head of Antibody Therapy
何苗壮博士,美国国家研究院国家肿瘤研究所资深研究员，抗体治疗主管,《Antibody Therapeutics》杂志主编
Integrated omics to define molecular heterogeneity in liver cancer
基于综合基因组学的肝癌发病机理研究
Xinwei Wang, Deputy Chief, Laboratory of Human Carcinogenesis, Co-Director, Liver Cancer Program, Center for Cancer Research, NCI, NIH
王心伟博士, 美国国立卫生研究院国家肿瘤研究所，人类致癌作用研究实验室副主任，肝癌项目联合主任
Cancer Immunotherapy: Anti-PD-1/PD-L1 Therapies and Beyond
肿瘤免疫治疗：抗PD-1/PDl-1和其它治疗
Xiaoqiang Kang, Ph.D., CEO for Nanjing leads Biolabs Co., Ltd
康小强博士 南京维立志博生物科技有限公司首席执行官
Discovery and Evaluation of Protease Inhibitory mAbs
蛋白酶抑制型单抗的开发和评价
Xin Ge, Associate Professor, University of California at Riverside
葛新博士, 加州大学河滨分校副教授
Forum 6: Precision Medicine 精准医学论坛
Chair/主席：Dr. Harry Yang and Ms. Yan Guo
杨宏钧博士,美国前阿斯利康肿瘤分子诊断和精准医疗高级主管，中国生物工程学会精准医学创始人
郭雁, 资深应用科学家，美国太平洋生物科学公司
Biomarkers in Lung Cancer and Companion Diagnostics in Clinical Practice
肺癌的生物标志物和伴随诊断在临床上应用
Dr. Judy Yu, Medical Diagnostic Director, AstraZeneca US Medical Affairs
余红，阿斯利康美国检测医学总监
The Cancer Genomics Projects (TCGA) and Precision Medicine
肿瘤基因组图谱和精准医学
Dr. Zhong Chen, Head and Neck Surgery Branch, National Institute on Deafness and other Communication Disorders, NIH
陈中，临床基因组学研究组组长, 头颈外科, 耳鼻喉及交流障碍研究所, 美国国立卫生研究院
Heterogenerity，migration and personalized treatment for breast cancer
乳腺癌的异质性，转移和个性化治疗
Dr. Xinmei Kang, Chief Physician, Department of Oncology, Xiang’an Hospital, Xiamen University
康欣梅 教授, 厦门大学附属翔安医院肿瘤科
Integration of Diagnosis Technologies with Medicine Plays Key Role in Future Precision Medicine
检验诊断技术在未来精准医疗中的重大作用
JianCheng Tu, PhD, Director of Medical Laboratory Program, Zhongnan hospital of Wuhan University
涂建成 教授, 武汉大学中南医院检验系主任
11:00-11:15
Break 茶歇
11:15-12:30
Forum 7: New Trend： Globalization of Drug Discovery and Development
药物研发和临床实践的全球化及各个相关参与方法
Chair/主席：申华琼, Joan (Huaqiong) Shen, Ph.D., M.D., Head of Research and Development, I-Mab Biopharma Co., Ltd.（天境生物）
Frank Li，Ph.D., M.D., CBA president， BLA Regulatory LLC, Former Head of Ascentage Pharma and Senior Director, Regulatory Affairs
Innovative Drug R&D for Chinese Parmaceuticals
中国创新药研发模式的探讨
Jian Li, PhD, VP, Wuxi AppTech
黎健, 药明康德副总裁
Salubris Strategic Approach to Innovation
信立泰生物创新药研发策略与布局
John Li, CEO or Salubris Biotherapeutics, Inc.
美国信立泰生物医药公司总裁
Biological Products Industrialization Equipment and Big Data
生物产品产业化装备与大数据
Xiangxian Shao,CEO, NaiLii Biotech Engineering
项宪绍，上海耐利制药设备工程有限公司总裁
Forum 8:
Latest Advancements of Therapeutic Methodologies
先进疗法的最新进展和应用
Chair/主席： Dr. Helen Mao 主席: 毛慧华博士
The Development and Clinical Trials of a Recombinant Ebola Virus Disease Vaccine
重组埃博拉病毒病疫苗的开发和临床实验
Dr. Helen Mao, Co-founder and Senior Vice President of CanSino Biologics Inc.
毛慧华博士, 康希诺生物股份公司共同创始人, 高级副总裁
Targeting TGF-β1 with PNP Delivered RNAi Trigger for Immune Oncology Application
针对TGF-β1的PNP 递送RNAi Trigger在免疫肿瘤上的应用
Dr. Patrick Lu, Founder, President and CEO of Sirnaomics Inc.
陆阳博士, 美国圣诺制药公司创始人, 总裁兼首席科学家
AAV vector technology for hemophilia A gene therapy
AAV载体技术用于血友病A基因治疗
Weidong Xiao, PhD，Professor, Microbiology and Immunology, Temple University
肖卫东博士, 天普大学微生物和免疫学教授, 美国农业部东部研究中心顾问
Challenges of developing gene therapy-based CAR T cells for oncology indications – from a small biotech company’s perspective
小型生物技术公司开发基于基因疗法的CAR T细胞用于肿瘤适应症的挑战
Xiaobin Victor Lu, PhD， Senior VP, Head of Regulatory Affairs at Innovative Cellular Therapeutics Inc.
吕小宾博士，高级副总裁，Innovative Cellular Therapeutics Inc.
12:30-13:30
Lunch and Networking
特别讲座（需事先预约，song.wu@cba-USA.org）
Trade Secrets – What are They and How are They Relevant to You in the Geopolitics of Today?
当今国际形势下与你息息相关的贸易秘诀；
Special Lunch Seminar, by Ropes and Gray ( Attend by Reservation with song.wu@cba-USA.org, Room# TBD)
13:30-14:45
Forum 9：Keynote Presentation
重磅演讲 引领生物医药尖端技术，推进医药产业化和全球合作 (三)
Current Status and Development of Proton Therapy Equipment
质子治疗装备的现状与发展
Dr. Mingwu Fan, Academician, Chinese Academy of Engeering, Huazhong University of Science and Technology
樊明武院士, 中国工程院院士, 华中科大
Challenges, Opportunities and Luck! Are You Ready for the Next Step?
挑战与机遇 ！ 你预备好了吗？
Samuel Mok, Formal Chief Financial Officer, US Department of Labor, Chairman at the National China Garden Foundation
莫天成 , 前美国劳工部副部长/财务总长, 美国国立中国园林基金会主席
14:45-16:15
Forum 10: Venture Capital, Biopharmaceutical Incubator, Intellectual Property Protection and Law in Pharmaceutical industry in China and the U.S.
产业和资本, 生物医药初创公司孵化器, 中美生物医药商务法规和知识产权论坛
Chair/主席：Lin Sun-Hoffman, Ph.D., J.D., Founding Partner in Liu, Chen & Hoffman, LLP; 孙霖博士，美国成美律师事务所创始合伙人, CBA前会长
Ping Chen, Ph.D., 陈平博士， 安宇生物公司创始人，执行总裁，CBA前会长
Biotech Investment and Cooperation Opportunity in China
中国生物技术投资与合作机遇
Lynn Yang, General Manager, Sequoia Capital
杨云霞，红杉资本中国基金董事总经理
Grasping development opportunities, Realizing Industry in Qixia District;
把握发展机遇，实现产业集聚–栖霞区生物医药产业推介
Xiaolin Zhao，Director of Business Bureau in Qixia District, Nanjing
赵晓琳，南京市栖霞商务局局长
Maryland’s Ecosystem for Biohealth Companies
马里兰卅生命科学产业的生态系统
Vikki Wang, Senior Account Manager at Maryland Center China, the Representative office of MD Department of Commerce in China.
王艳波，高级项目经理， 美国 马里兰卅驻华商务代表处
Biopharmaceutical Industry opportunities in Guangzhou
生物医药产业的广州机会
Yubin Zhong, Partner, Infinite Capital Holding Company
钟育彬, 广州民营投资股份有限公司 首席运营官,
Promotion of Huaihai Biomedical Industrial Park
淮海生物医药产业园推介
Dr. Youbin Zhou, CEO of Huayue Medical
邱又彬, 华越医疗CEO
16:15-16:30
Break 茶歇
16:30-18:25
Forum 11: Pitch Competition 创业路演大赛
Forum Moderator: Xu-Rong Jiang, MD., PhD, Quality and Technical Director of AstraZeneca BioVentures
Dazhi Lai, PhD, CEO，SPEED Biosystems
Wenlong Wang, Vice President for Youth Talent, CBA-USA
论坛主席：姜绪荣博士, 美国阿斯利康制药公司质量和技术总监
来大志博士, 美国Speed Biosystems 创始人，CBA-USA 副会长
汪文龙, CBA-USA 青年学者副会长Expert committee, combined with speakers and Panelists from Forum 10
评审: Forum10 的投行及其他专业评审
16:30-18:25
Closing Remarks CBA-USA 广州年会正式结束
CBA-USA President-elect Dr. Chuanhua Julia Xing
年会主席，CBA-USA候任会长邢传华博士
Optional：
Day Three: 12 Jun 2019 Wednesday
9:00 -TBD 广州园区考察
Optional：
Day Four: 13 Jun 2019 Thursday
9:00-TBD 第二届中美生物医药论坛暨CBA2019年会四川分会, 成都
Optional：
Day Five: 14 Jun 2019 Friday
9:00-TBD 园区考察与深度交流、成都文化体验
About CBA
CBA is one of the largest Chinese American professional associations in the US. Founded in 1995, CBA is an independent, non-political, not-for-profit professional organization, with more than 8,000 members, of which over 80% have Ph.D. degrees. Many internationally renowned scientists including Nobel laureates, business leaders, and high-ranking US and Chinese government officials have attended and spoken at CBA’s annual conferences. CBA’s events and members have been covered by a number of prestigious scientific journals, business magazines, and news media such as Nature, Science, Thomson Reuters, China Central Television (CCTV), PR Newswire, BioPortfolio, and Bioprocess International.
CBA is headquartered in the Greater Washington area, which is the US’s leading biotech cluster. Many of CBA’s members work at renowned institutions, research facilities, biotech/pharmaceutical companies, and top universities in the world, including the FDA, National Institutes of Health, AstraZeneca/MedImmune, GlaxoSmithKline, Johns Hopkins University, George Washington University, Georgetown University, and University of Maryland.
About BioChina
BioChina (https://www.biochina-gz.com/) is the largest annual event for the bioindustry in China. Initiated in 2007, it attracts up to 10,000 attendees each year, including government representatives, scientists, entrepreneurs, investors, and others in the field. Through the years, BioChina has grown into a high-level, large-scale annual event in the field of bioindustry.
关于美国华人生物医药协会（CBA）
CBA是美国最大的华裔专业协会之一。 CBA成立于1995年，是一个独立的，非政治性的，非营利性专业组织，拥有8000多名成员，其中80％以上拥有博士学位。许多国际知名科学家，包括诺贝尔奖获得者，商界领袖，以及美国和中国政府高级官员，都出席过CBA的年会。 CBA的活动和成员已被许多著名的科学期刊，商业杂志和新闻媒体报道，如自然，科学，汤森路透，中国中央电视台（CCTV），美通社，BioPortfolio和Bioprocess International。
CBA总部位于大华盛顿地区，这里美国领先的生物技术集群。许多CBA成员在世界知名机构，研究机构，生物技术/制药公司和顶尖大学工作，包括美国食品药品监督管理局，美国国立卫生研究院，阿斯利康，葛兰素史克，约翰霍普金斯大学，乔治华盛顿大学，乔治城大学，和马里兰大学。
关于中国生物产业大会BioChina
中国生物产业大会（http://www.bio-industry.org.cn/index.html）是中国最大的生物产业年度盛会。 该项目始于2007年，每年吸引10,000名与会者，包括政府代表，科学家，企业家，投资者以及该领域的其他人士。 多年来，BioChina已发展成为生物工业领域的高水平，大型年度盛会。
关于美国华人生物医药协会（CBA）
CBA是美国最大的华裔专业协会之一。 CBA成立于1995年，是一个独立的，非政治性的，非营利性专业组织，拥有8000多名成员，其中80％以上拥有博士学位。许多国际知名科学家，包括诺贝尔奖获得者，商界领袖，以及美国和中国政府高级官员，都出席过CBA的年会。 CBA的活动和成员已被许多著名的科学期刊，商业杂志和新闻媒体报道，如自然，科学，汤森路透，中国中央电视台（CCTV），美通社，BioPortfolio和Bioprocess International。
CBA总部位于大华盛顿地区，这里美国领先的生物技术集群。许多CBA成员在世界知名机构，研究机构，生物技术/制药公司和顶尖大学工作，包括美国食品药品监督管理局，美国国立卫生研究院，阿斯利康，葛兰素史克，约翰霍普金斯大学，乔治华盛顿大学，乔治城大学，和马里兰大学。
关于中国生物产业大会BioChina
中国生物产业大会（http://www.bio-industry.org.cn/index.html）是中国最大的生物产业年度盛会。 该项目始于2007年，每年吸引10,000名与会者，包括政府代表，科学家，企业家，投资者以及该领域的其他人士。 多年来，BioChina已发展成为生物工业领域的高水平，大型年度盛会。